Concepedia

Paola Perrotta

PP

Statistics

Publications

7

Citations

350

H-Index

7

Active since

2015

Affiliations

University of Antwerp(Current)

Yale University

Antwerp University Hospital

Miragen Therapeutics (United States)

Paola Perrotta is an author at University of Antwerp specializing in life sciences, inflammation, and glycolysis.

ORCID

Publications per year

2015–2021

7

Publications

7

Chronic miR‐29 antagonism promotes favorable plaque remodeling in atherosclerotic mice

Victoria Ulrich, Noemí Rotllán, Elisa Araldi et al. · EMBO Molecular Medicine · 2016 · 83 citations · Full text

, , +17

Endothelial miR-17∼92 cluster negatively regulates arteriogenesis via miRNA-19 repression of WNT signaling

Shira Landskroner-Eiger, Cong Qiu, Paola Perrotta et al. · Proceedings of the National Academy of Sciences · 2015 · 67 citations · Full text

, , +17

Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice

Paola Perrotta, Bieke Van der Veken, Pieter Van der Veken et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2020 · 67 citations · Full text

, , +15

Small molecule 3PO inhibits glycolysis but does not bind to 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase‐3 (PFKFB3)

Besa Emini Veseli, Paola Perrotta, Pieter Van Wielendaele et al. · FEBS Letters · 2020 · 50 citations · Full text

, , +17

Endothelial cell–glucocorticoid receptor interactions and regulation of Wnt signaling

Han Zhou, Sameet Mehta, Swayam Prakash Srivastava et al. · JCI Insight · 2020 · 43 citations · Full text

, , +17

1–5 of 7